United States · FDA National Drug Code directory
REZZAYO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70842-240_32d9ddc4-232f-45f9-ab7d-a34c46cf9b1c
- Product NDC
- 70842-240
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- rezafungin
- Labeler
- Melinta Therapeutics, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230609
- Source listing expiry
- 20271231
Source-listed ingredients
- REZAFUNGIN — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (70842-240-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL · 70842-240-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →